Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long Term Safety of Ciclesonide Nasal Spray in Perennial Allergic Rhinitis
NCT00163501Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Dec 2003
- Primary completion
- Apr 2005
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of ciclesonide in perennial allergic rhinitis (PAR), sponsored by AstraZeneca. Started Dec 2003; status: completed.
02
Drugs
ciclesonide
03
Conditions
perennial allergic rhinitis (PAR)
Beyond the preview
Go deeper on NCT00163501.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00163501.